Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Antibiotic therapy and the gut microbiome: investigating the effect of delivery route on gut pathogens

Kelly, Stephen A., Nzakizwanayo, Jonathan, Rodgers, Aoife M., Zhao, Li, Weiser, Rebecca ORCID:, Tekko, Ismaiel A., McCarthy, Helen O., Ingram, Rebecca J., Jones, Brian V., Donnelly, Ryan F. and Gilmore, Brendan F. 2021. Antibiotic therapy and the gut microbiome: investigating the effect of delivery route on gut pathogens. ACS Infectious Diseases 7 (5) , 1283–1296. 10.1021/acsinfecdis.1c00081

[thumbnail of Antibiotic+Therapy+and+the+Gut+Microbiome.pdf] PDF - Accepted Post-Print Version
Download (1MB)


The contribution of the gut microbiome to human health has long been established, with normal gut microbiota conferring protection against invasive pathogens. Antibiotics can disrupt the microbial balance of the gut, resulting in disease and the development of antimicrobial resistance. The effect of antibiotic administration route on gut dysbiosis remains under-studied to date, with conflicting evidence on the differential effects of oral and parenteral delivery. We have profiled the rat gut microbiome following treatment with commonly prescribed antibiotics (amoxicillin and levofloxacin), via either oral or intravenous administration. Fecal pellets were collected over a 13-day period and bacterial populations were analyzed by 16S rRNA gene sequencing. Significant dysbiosis was observed in all treatment groups, regardless of administration route. More profound dysbiotic effects were observed following amoxicillin treatment than those with levofloxacin, with population richness and diversity significantly reduced, regardless of delivery route. The effect on specific taxonomic groups was assessed, revealing significant disruption following treatment with both antibiotics. Enrichment of a number of groups containing known gut pathogens was observed, in particular, with amoxicillin, such as the family Enterobacteriaceae. Depletion of other commensal groups was also observed. The degree of dysbiosis was significantly reduced toward the end of the sampling period, as bacterial populations began to return to pretreatment composition. Richness and diversity levels appeared to return to pretreatment levels more quickly in intravenous groups, suggesting convenient parenteral delivery systems may have a role to play in reducing longer term gut dysbiosis in the treatment of infection.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
Publisher: American Chemical Society
ISSN: 2373-8227
Date of First Compliant Deposit: 15 June 2021
Date of Acceptance: 16 February 2021
Last Modified: 07 Nov 2023 02:28

Citation Data

Cited 5 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics